InvestorsHub Logo
Followers 2
Posts 2974
Boards Moderated 0
Alias Born 06/23/2017

Re: None

Wednesday, 03/07/2018 8:00:20 PM

Wednesday, March 07, 2018 8:00:20 PM

Post# of 44784
Some words I found from the first born. Highly touts the speed of Japanese pathway. Did I miss the technique he spews? Design of the trial was accepted by the PMDA back in Dec of 2015. Wonder why partnerships elude us. Stuck in the twilight zone he is. This guy is truly delirious and an absolute joke. .

“The improvement of our CLI program in the course of the speeded up regulatory pathway may just permit a extra fast front into the sizeable Jap marketplace, as has been our technique,” mentioned Zami Aberman, Pluristem’s chairman and CEO.

https://nextstepnews.website/business/how-japan-is-creating-new-opportunities-in-the-field-of-regenerative-medicine-sponsor-content-from-the-government-of-japan/